Investors Careers Therapeutic Areas News Resources About Us Contact Us Heart Valves As of June 1, 2021, LivaNova and CORCYM completed the initial closing relating to CORCYM’s acquisition of the LivaNova heart valve business. In the initial closing, CORCYM acquired LivaNova manufacturing facilities in Saluggia and Vancouver and related assets in other geographies, representing most of the heart valve business. During the course of 2021, the parties expect to complete the transfer of the commercial operations in various local jurisdictions. Visit www.corcym.com for more information. The information contained on or linked from www.corcym.com, and any other website hosted or provided by CORCYM, is provided solely by CORCYM, and LivaNova has no liability or responsibility for it. Visit Heart Valve Products Therapeutic Areas Advanced Circulatory Support Cardiopulmonary Difficult-to-Treat Depression Drug-Resistant Epilepsy Heart Failure Heart Valves Obstructive Sleep Apnea Resources Contact Us Customer Service Research Support Request Donations & Grants About Us Leadership Ethics & Compliance Modern Slavery Statement Conflict Minerals Terms of Use Privacy Statement Privacy Notice Patents Cookie Policy © 2020 LivaNova PLC LivaNova PLC - Registered in England and Wales - Registered No. 09451374 - 20 Eastbourne Terrace, London, W2 6LG, United Kingdom LivaNova Cookie Consent By clicking “Accept Cookies”, you agree to the storing all cookies on your device to enhance site navigation, analyze site usage, and assist in our efforts to deliver well-tailored marketing services Link to Cookie Policy Cookies Settings Accept Cookies